Come up with a name for your new list and we'll add to it:
Aukera Therapeutics raised a round of funding on May 10, 2010. Investors include
MIT $100K Entrepreneurship Competition.
Aukera Therapeutics is developing a novel therapeutic for the treatment of Amyotrophic Lateral Sclerosis (ALS) also known as Lou Gehrig's disease.…